Acquired Point Mutations of TKD Are Responsible for Sorafenib Resistance in FLT3-ITD Mutant AML,
暂无分享,去创建一个
M. Konopleva | M. Andreeff | J. Cortes | F. Ravandi | G. Borthakur | Wenjing Chen | Weiguo Zhang | R. Jacamo
暂无分享,去创建一个
M. Konopleva | M. Andreeff | J. Cortes | F. Ravandi | G. Borthakur | Wenjing Chen | Weiguo Zhang | R. Jacamo